About the ESC Council on Valvular Heart Disease
Why we focus on valvular heart disease
- Valvular heart disease (VHD) affect millions of people worldwide and this number is growing with an ageing population
- A wealth of new knowledge from trials and other sources is informing how we can treat patients with these conditions
- Despite transformative advances such as TAVI, this field is generating many new challenges which must be addressed
Our objectives
The council is dedicated to advancing the field of valvular heart disease (VHD) by supporting fundamental research, fostering knowledge among both cardiologists and non-cardiologists, and improving the overall management of VHD – from early screening and diagnosis to effective treatment and long-term care.
What we offer
The council unites experts across a truly interdisciplinary field, from cardiovascular imagers, interventional cardiologists and cardiovascular surgeons to congenital heart disease specialists and basic scientists.
Together we will support VHD research, develop and share knowledge across expertise and improve the pathway from screening to treatment.
How we work
The council is led by a nucleus which drives the council’s activities over a two-year mandate.
Nucleus Members 2024–2026
Professor Susanna Price
Vice-President Representative
Doctor Fabien Praz
Secretary
Associate Professor Anna Sonia Petronio
Chairpersonn
Professor Philipp Lurz
Treasurer
Doctor Victoria Delgado
Chairperson-Elect
Professor Sabine Bleiziffer
Nucleus Member
Associate Professor Marianna Adamo
Communications Coordinator